Benefits of Extracorporeal Shock Wave Therapy to Reduce Spasticity in Cerebral Palsy and Stroke Patients
Background: Spasticity, a common issue in cerebral palsy and stroke patients, significantly impairs mobility and quality of life. Non-invasive treatments like Extracorporeal Shock Wave Therapy (ESWT) have been explored for spasticity reduction.Objective: To evaluate the effectiveness of ESWT in reducing spasticity in cerebral palsy (CP) and stroke patients using the Modified Ashworth Scale (MAS).Methods: A randomized controlled trial (RCT) was conducted on 28 spastic CP and stroke patients. Participants were divided into Group A (n = 14, ESWT combined with conventional physiotherapy) and Group B (n = 14, conventional physiotherapy only). ESWT was administered at 5 Hz frequency, 0.10 mJ/mm² energy flux density, and 1500 impulses per session for 30 minutes, 5 days a week, for 6 months. Spasticity was assessed using MAS pre- and post-intervention. Data were analyzed using IBM SPSS version 25.Results: The ESWT group showed a significant reduction in MAS scores from 3.21 ± 0.25 to 1.77 ± 0.37 (p < 0.001), compared to the control group (3.10 ± 0.44 to 2.36 ± 0.60; p < 0.001).Conclusion: ESWT significantly reduced spasticity in CP and stroke patients, demonstrating its potential as an adjunctive therapy.
Authors
- Gulnaz Yamin
- Rafia Imtiaz
- Qudosia Jalal
- Zoha Soomar Patoli
- Z Bal
- Adiba Javed
- Ammara Jabeen
- Anum Kabir
Institutions
- University of Azad Jammu and Kashmir (PK)
- Government College University, Faisalabad (PK)
- Rashid Latif Medical College (PK)
- Superior University (PK)
- Mayo Hospital (PK)
- University of Faisalabad (PK)
- Mirpur University of Science and Technology (PK)
Publication Details
- Journal
- Journal of Health and Rehabilitation Research
- Published
- 2024-09-30
- DOI
- https://doi.org/10.61919/jhrr.v4i3.1360
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00